Next Article in Journal
A Phase 2a, Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy and Safety of ALS-L1023 in Non-Alcoholic Fatty Liver Disease
Next Article in Special Issue
Patient-Derived Cellular Models for Polytarget Precision Medicine in Pantothenate Kinase-Associated Neurodegeneration
Previous Article in Journal
Oleoylethanolamide Protects against Acute Ischemic Stroke by Promoting PPARα-Mediated Microglia/Macrophage M2 Polarization
 
 
Article

Article Versions Notes

Pharmaceuticals 2023, 16(4), 622; https://doi.org/10.3390/ph16040622
Action Date Notes Link
article xml file uploaded 20 April 2023 10:58 CEST Original file -
article xml uploaded. 20 April 2023 10:58 CEST Update -
article pdf uploaded. 20 April 2023 10:58 CEST Version of Record https://www.mdpi.com/1424-8247/16/4/622/pdf-vor
article html file updated 20 April 2023 11:00 CEST Original file -
article xml file uploaded 21 April 2023 03:25 CEST Update -
article xml uploaded. 21 April 2023 03:25 CEST Update https://www.mdpi.com/1424-8247/16/4/622/xml
article pdf uploaded. 21 April 2023 03:25 CEST Updated version of record https://www.mdpi.com/1424-8247/16/4/622/pdf
article html file updated 21 April 2023 03:27 CEST Update https://www.mdpi.com/1424-8247/16/4/622/html
Back to TopTop